{"id":"propylhexedrine","rwe":[],"_fda":{"id":"2888acff-4fa4-a9d7-e063-6394a90a7eda","set_id":"00d8c237-3eee-1d9f-e063-6394a90aeb86","openfda":{"unii":["LQU92IU8LL"],"route":["NASAL"],"spl_id":["2888acff-4fa4-a9d7-e063-6394a90a7eda"],"brand_name":["BENZEDREX"],"spl_set_id":["00d8c237-3eee-1d9f-e063-6394a90aeb86"],"package_ndc":["0225-0611-23"],"product_ndc":["0225-0611"],"generic_name":["PROPYLHEXEDRINE"],"product_type":["HUMAN OTC DRUG"],"substance_name":["PROPYLHEXEDRINE"],"manufacturer_name":["BF ASCHER AND CO INC"],"application_number":["M012"],"is_original_packager":[true]},"purpose":["Uses Temporarily relieves nasal congestion due to a cold, hay fever, or other upper respiratory allergies (allergic rhinitis)."],"version":"2","warnings":["Warnings Do not exceed recommended dosage. This product may cause temporary discomfort such as burning, stinging, sneezing, or an increase in nasal discharge. The use of this container by more than one person may spread infection. Use only as directed. Frequent or prolonged use may cause nasal congestion to recur or worsen. Ill effects may result if taken internally"],"questions":["Questions? Call 1-800-324-1880, 7:30am - 4:00pm Central, Mon. - Fri., or visit us at www.bfascher.com"],"ask_doctor":["Stop use and consult a doctor if symptoms persist."],"do_not_use":["Do not use this product for more than three days."],"effective_time":"20241205","active_ingredient":["Active ingredient................. Purpose Propylhexedrine 175 mg......Nasal decongestant"],"inactive_ingredient":["Inactive ingredients lavender oil, menthol"],"instructions_for_use":["Directions adults and children 6 to 12 years of age (with adult supervision): two inhalations in each nostril not more than every two hours. children under 6 years of age: consult a doctor"],"storage_and_handling":["Other information store at 59°-86° F (15°-30° C) keep inhaler tightly closed mfd. in USA for B.F. Ascher & Co., Inc. this inhaler is effective for a minimum of 3 months after first use"],"indications_and_usage":["Uses For the temporarily relief of nasal congestion due to a cold, hay fever, or other upper respiratory allergies (allergic rhinitis)."],"dosage_and_administration":["Directions adults and children 6 to 12 years of age (with adult supervision): two inhalations in each nostril not more than every two hours. children under 6 years of age: consult a doctor"],"spl_product_data_elements":["BENZEDREX PROPYLHEXEDRINE LAVENDER OIL MENTHOL PROPYLHEXEDRINE PROPYLHEXEDRINE"],"pregnancy_or_breast_feeding":["If pregnant or breast-feeding, ask a health professional before use."],"keep_out_of_reach_of_children":["Keep this and all drugs out of reach of children. In case of overdose or ingestion of contents, get medical help or contact a poison control center immediately."],"package_label_principal_display_panel":["Benzedrex"]},"tags":[{"label":"propylhexedrine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Nasal","category":"route"},{"label":"Inhalant","category":"form"},{"label":"Active","category":"status"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG ABUSE","source":"FDA FAERS","actionTaken":"11 reports"},{"date":"","signal":"DRUG DEPENDENCE","source":"FDA FAERS","actionTaken":"11 reports"},{"date":"","signal":"ACUTE KIDNEY INJURY","source":"FDA FAERS","actionTaken":"10 reports"},{"date":"","signal":"TOXICITY TO VARIOUS AGENTS","source":"FDA FAERS","actionTaken":"10 reports"},{"date":"","signal":"HYPOTENSION","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"METABOLIC ACIDOSIS","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"PNEUMONIA ASPIRATION","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"RESPIRATORY DEPRESSION","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"TACHYCARDIA","source":"FDA FAERS","actionTaken":"9 reports"},{"date":"","signal":"DEPRESSED LEVEL OF CONSCIOUSNESS","source":"FDA FAERS","actionTaken":"8 reports"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=PROPYLHEXEDRINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:06:18.893341+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T01:06:39.153974+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:06:24.562987+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PROPYLHEXEDRINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:06:25.343844+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:06:17.643527+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:06:33.811794+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:06:17.643555+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:06:26.962801+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105275/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:06:26.138400+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M012","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:06:17.643560+00:00"}},"allNames":"benzedrex","offLabel":[],"synonyms":["propylhexedrine","benzedrex","DL-propylhexedrine","hexahydrodesoxyephedrine","hydromethamphetamine","propylhexadrine","propylhexedrin"],"timeline":[],"aiSummary":"Propylhexedrine, marketed as Benzedrex, is a nasal decongestant currently available in the over-the-counter market. Its key strength lies in its mechanism of action, which effectively stimulates the nasal mucosa to reduce swelling and increase airflow, providing rapid relief for nasal congestion. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generic alternatives.","approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"brandName":"Benzedrex","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"propylhexedrine","explanation":"","oneSentence":"","technicalDetail":"Propylhexedrine, the active ingredient in Benzedrex, is a sympathomimetic agent that acts as an alpha-adrenergic agonist, causing vasoconstriction and reducing nasal mucosal swelling."},"commercial":{"revenueYear":2025,"annualRevenue":172,"revenueSource":"Teva 2026-02-03 (verified from SEC filing)","revenueCurrency":"USD","revenueConfidence":"high"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2305","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=PROPYLHEXEDRINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:27:13.933810","_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:06:39.154058+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"propylhexedrine","indications":{"approved":[{"id":"propylhexedrine-nasal-congestion-relief","name":"Nasal Congestion Relief","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Individuals experiencing nasal congestion due to a cold, hay fever, or other upper respiratory allergies","pivotalTrial":null,"restrictions":[],"patientPopulation":"Individuals experiencing nasal congestion due to a cold, hay fever, or other upper respiratory allergies","diagnosticRequired":null,"brandNameForIndication":"Benzedrex"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Nasal","formulation":"Inhalant","formulations":[{"form":"INHALANT","route":"NASAL","productName":"BENZEDREX"},{"form":"INHALANT","route":"NASAL","productName":"BENZEDREX09-19-2014"}]},"crossReferences":{"NUI":"N0000190761","MMSL":"11906","NDDF":"001805","UNII":"LQU92IU8LL","VUID":"4033392","CHEBI":"CHEBI:134783","VANDF":"4033392","INN_ID":"566","RXNORM":"227666","UMLSCUI":"C0033508","chemblId":"CHEMBL2105275","ChEMBL_ID":"CHEMBL2105275","KEGG_DRUG":"D05637","DRUGBANK_ID":"DB06714","PUBCHEM_CID":"7558","SNOMEDCT_US":"398882009","MESH_SUPPLEMENTAL_RECORD_UI":"C084814"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":44,"therapeuticAreas":["Other"],"_revenueScrapedAt":"2026-03-31 14:09:35.487336+00","biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T01:06:39.154058+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}